RANI - Rani Therapeutics Holdings Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript
Rani Therapeutics Holdings, Inc. (RANI) Q4 2021 Earnings Conference Call March 29, 2022, 04:30 PM ET Company Participants Laurence Watts - Managing Director, Gilmartin Group LLC Talat Imran - CEO Svai Sanford - Chief Financial Officer Mir Hashim - Chief Scientific Officer Conference Call Participants Geoff Meacham - Bank of America Annabel Samimy - Stiefel Michelle Gilson - Canaccord Genuity Brandon Folkes - Cantor Fitzgerald Presentation Operator Welcome to Rani Therapeutics Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are a in a listen-only mode. Following management's prepared remarks, we'll hold a question-and-answer session. To ensure that we have ample time to adjust everyone's questions during the Q&A session, we'll ask for a limit of one question and one follow-up question per person. [Operator instructions] As a reminder, this call is being recorded today Tuesday, March 29, 2022. I'd now
For further details see:
Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript